News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–51
Matches
51
Sources here
6
Companies here
1
Search results Stored financial headlines

Active search

51 matching headlines

Ticker or company: ARVNMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

TradingKey Market update Main company 🇺🇸 United States

Arvinas Inc (ARVN) Institutional Confidence

Arvinas Inc (ARVN) has an institutional shareholding score of 7.00, placing it 80th out of 384 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 83.59%, which is a 50.35% decrease quarter-over-quarter. Bill Nygren | OAKMX is the largest institutional shareholder, …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Traders Daily Market update Main company 🇺🇸 United States

Technical Reactions to ARVN Trends in Macro Strategies

This article provides a technical analysis of Arvinas Inc. (NASDAQ: ARVN), highlighting a neutral near-term sentiment with potential for moderate mid-term weakness. It identifies a significant risk-reward setup targeting a 30.2% gain versus a 0.3% risk. The analysis also details institutional trading strategies, including …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
GlobeNewswire Earnings Main company 🇺🇸 United States

Arvinas to Report Second Quarter 2026 Financial Results on August 4, 2026

Arvinas, Inc. (Nasdaq: ARVN) announced it will report its second quarter 2026 financial results and provide a corporate update during a live webcast on Tuesday, August 4, 2026, at 8:00 a.m. ET. The webcast will be available on the investor page of the Arvinas …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Titan Earnings Main company 🇺🇸 United States

Arvinas to give corporate update during Aug. 4 webcast

Arvinas (Nasdaq: ARVN) announced it will host a live webcast on August 4, 2026, at 8:00 a.m. ET, to discuss its second-quarter 2026 financial results and provide a corporate update. The biotechnology company, known for its PROTAC protein degrader platform and co-development of the …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Arvinas Inc (ARVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Arvinas Inc (ARVN), focusing on business segments and regional contributions. However, it notes that relevant data for FY2025 (Q1-Q4) and FY2024-2023 has not yet been disclosed by the company, though it lists US revenue at $262.60M with …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Arvinas, Inc. $ARVN is Rangeley Capital LLC's 8th Largest Position

Rangeley Capital LLC reduced its stake in Arvinas, Inc. (NASDAQ:ARVN) by 43.4% in the first quarter, making the stock its 8th largest holding. Despite this, institutional investors and hedge funds own 95.19% of the company. Arvinas reported a quarterly loss of $0.90 per share, …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Arvinas (NASDAQ:ARVN) Upgraded at Wall Street Zen

Wall Street Zen upgraded Arvinas (NASDAQ:ARVN) from a "strong sell" to a "sell," while other analysts maintain a "Hold" consensus with an average target price of $15.42. The biopharmaceutical company recently reported a smaller-than-expected quarterly loss but saw a sharp decline in revenue, and …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

TradingKey

This article provides a detailed quarterly and annual income statement for Arvinas Inc (ARVN), offering insights into its financial performance, including revenue, operating expenses, and net income. It presents a comprehensive historical data series for various financial metrics, along with an FAQ section explaining …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Earnings Main company 🇺🇸 United States

Arvinas Inc (ARVN) Balance Sheet

This article provides a detailed quarterly and annual balance sheet for Arvinas Inc (ARVN), allowing users to evaluate financial health, analyze fundamentals, and calculate key ratios. It includes data on various assets, liabilities, and shareholders' equity components, along with FAQs explaining important balance sheet …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Analyst action Main company 🇺🇸 United States

Arvinas, Inc. (NASDAQ:ARVN) Receives Consensus Rating of "Hold" from Analysts

Arvinas, Inc. (NASDAQ:ARVN) has received a consensus "Hold" rating from thirteen analysts, with an average 12-month price target of $15.42. The company's stock is currently trading around $8.03, below its 200-day moving average. Despite reporting a smaller-than-expected loss in its latest quarterly results, revenue …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
MarketBeat Earnings Main company 🇺🇸 United States

Caxton Associates LLP Decreases Stake in Arvinas, Inc. $ARVN

Caxton Associates LLP reduced its stake in Arvinas, Inc. by 42.8% in the first quarter, selling 194,501 shares to hold 260,016 shares valued at $2.76 million. This reduction comes amid mixed Wall Street sentiment, with a "Hold" consensus rating and recent insider sales by …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
TradingKey Market update Main company 🇺🇸 United States

ARVN|Arvinas Inc|Price:8.030|Chg%:-0.090

Arvinas Inc. (ARVN) is a clinical-stage biotechnology company focused on developing protein degradation therapies. The company's stock is currently priced at $8.030, reflecting a -1.11% change from its previous close. Despite recent average stock market performance, its fundamentals are considered healthy with significant growth …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Quartr Earnings Main company 🇺🇸 United States

Arvinas (ARVN) AGM 2026 Summary

This article summarizes Arvinas's (ARVN) 2026 Annual General Meeting (AGM), which was held virtually on June 24, 2026. Key outcomes included the approval of Class II directors, the passage of an advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Quartr Earnings Main company 🇺🇸 United States

Arvinas (ARVN) Proxy filing Summary

Arvinas (ARVN) released a summary of its proxy filing, detailing the upcoming annual meeting on June 24, 2026. Shareholders will vote on director elections, executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor. The board recommends voting for all …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026
Stock Traders Daily Market update Main company 🇺🇸 United States

Trading the Move, Not the Narrative: (ARVN) Edition

This article analyzes Arvinas Inc. (NASDAQ: ARVN) using AI models to provide trading strategies based on different risk profiles and holding periods. It highlights weak near-term sentiment but long-term strength, with specific entry, target, and stop-loss levels for position trading, momentum breakout, and risk …

ARVN main company
Sharemaestro market context Price below Trend Line 52 weeks +22.5% ARVN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context